# Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

> **NCT05868408** · NA · RECRUITING · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 234 (estimated)

## Conditions studied

- Infant Nutritional Physiological Phenomena
- Infant Formula
- Infant Health
- Infant Development
- Growth and Development

## Interventions

- **OTHER:** Control Formula
- **OTHER:** Experimental Formula 1
- **OTHER:** Experimental Formula 2

## Key facts

- **NCT ID:** NCT05868408
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-17
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868408, "Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05868408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*